Large arteries and the kidney

Journal of the American Society of Hypertension - Tập 1 - Trang 169-177 - 2007
Michel E. Safar1,2, Tewfik Nawar3, Gérard E. Plante3,4,5,6
1Faculty of Medicine, Paris Descartes University, Paris, France
2Diagnosis Center, Hôtel-Dieu Hospital (AP-HP), Paris, France
3Department of Medicine (Nephrology), University of Sherbrooke, Québec, Canada
4Department of Physiology, University of Sherbrooke, Québec, Canada
5Department of Pharmacology, University of Sherbrooke, Québec, Canada
6Institute of Geriatrics, University of Sherbrooke, Québec, Canada

Tài liệu tham khảo

Sarnak, 2003, Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention, Hypertension, 42, 1050, 10.1161/01.HYP.0000102971.85504.7c Shlipak, 2005, Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors, JAMA, 293, 1737, 10.1001/jama.293.14.1737 Dahlöf, 2002, Cardiovascular morbidity and mortality in the Losartan Intervention End point reduction in hypertension study (LIFE): a randomized trial against atenolol, Lancet, 359, 995, 10.1016/S0140-6736(02)08089-3 Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Lewis, 2001, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes, N Engl J Med, 345, 851, 10.1056/NEJMoa011303 Jafar, 2003, Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis, Ann Intern Med, 139, 244, 10.7326/0003-4819-139-4-200308190-00006 Youshauddin, 2005, The kidney and hypertension, 255 Safar, 2002, Central pulse pressure and mortality in end-stage renal disease, Hypertension, 39, 735, 10.1161/hy0202.098325 London, 1996, Cardiac and arterial interactions in end-stage renal disease, Kidney Int, 50, 600, 10.1038/ki.1996.355 London, 1998, Large artery structure and function in hypertension and end-stage renal disease, J Hypertens, 16, 1931, 10.1097/00004872-199816121-00012 Hope, 2005, Waveform dispersion, not reflection, may be the major determinant of aortic pressure wave morphology, Am J Physiol Heart Circ Physiol, 289, H2497, 10.1152/ajpheart.00411.2005 Foley, 1998, Clinical epidemiology of cardiovascular disease in chronic renal disease, Am J Kidney Dis, 32, S112, 10.1053/ajkd.1998.v32.pm9820470 Jono, 2000, Phosphate regulation of vascular smooth muscle cell calcification, Circ Res, 87, E10, 10.1161/01.RES.87.7.e10 Blumenthal, 1944, Calcification of the media of the lumen aorta and its relationship to intimal arteriosclerosis, aging and disease, Am J Pathol, 20, 665 Saglikes, 1985, Effect of phosphate depletion on blood pressure and vascular reactivity to norepinephrine and angiotensin II in the rat, Am J Physiol Renal Physiol, 248, F93, 10.1152/ajprenal.1985.248.1.F93 Blacher, 1999, Impact of aortic stiffness on survival in end-stage renal failure, Circulation, 99, 2434, 10.1161/01.CIR.99.18.2434 Guerin, 2001, Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure, Circulation, 103, 987, 10.1161/01.CIR.103.7.987 Mourad, 1997, Increased stiffness of radial artery wall material in end-stage renal disease, Hypertension, 30, 1425, 10.1161/01.HYP.30.6.1425 Acar, 1991, Comparative anatomy and histology of the radial artery and the internal thoracic artery: implication for coronary bypass, Surg Radiol Anat, 13, 283, 10.1007/BF01627759 Amann, 1995, Changes of vascular architecture independent of blood pressure in experimental uremia, Am J Hypertens, 8, 409, 10.1016/0895-7061(94)00248-A Amann, 1997, Aortic changes in experimental renal failure, hyperplasia or hypertrophy of smooth muscle cells?, Hypertension, 29, 770, 10.1161/01.HYP.29.3.770 Farand, 2007, Structure of large arteries: orientation of elastin in rabbit aortic internal elastic lamina and in the elastic lamellae of aortic media, Microvasc Res, 73, 95, 10.1016/j.mvr.2006.10.005 Mourad, 2001, Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension, Kidney Int, 59, 1834, 10.1046/j.1523-1755.2001.0590051834.x Briet, 2006, Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease, Kidney Int, 69, 350, 10.1038/sj.ki.5000047 Gosse, 2005, Arterial stiffness and plasma creatinine in untreated hypertensive patients, Am J Hypertens, 18, 1140, 10.1016/j.amjhyper.2005.04.008 Benetos, 2002, Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period, Circulation, 105, 1202, 10.1161/hc1002.105135 Abedin, 2004, Vascular calcification: mechanisms and clinical ramifications, Arterioscler Thromb Vasc Biol, 24, 1161, 10.1161/01.ATV.0000133194.94939.42 Shanahan, 2005, Vascular calcification, Curr Opin Nephrol Hypertens, 14, 361, 10.1097/01.mnh.0000172723.52499.38 Block, 2001, Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis), Curr Opin Nephrol Hypertens, 10, 741, 10.1097/00041552-200111000-00003 Blacher, 2001, Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease, Hypertension, 38, 938, 10.1161/hy1001.096358 Et-Taouil, 2000, Une anomalie du récepteur B2 de la bradykinine précède l’apparition de l’hypertension artérielle chez le rat spontanément hypertendu, Arch Mal Coeur Vaiss, 93, 40 Plante, 1989, Urinary phosphate excretion determines the progression of renal disease, Kidney Int Suppl, 27, S128 Essalihi, 2005, Regression of medial elastocalcinosis in rat aorta: a new vascular function for carbonic anhydrase, Circulation, 112, 1628, 10.1161/CIRCULATIONAHA.104.528984 Pickkers, 1999, Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide, Hypertension, 33, 1043, 10.1161/01.HYP.33.4.1043 Relman, 1961, Endogenous production of fixed acid and the measurement of the net balance of acid in normal subjects, J Clin Invest, 40, 1621, 10.1172/JCI104384 Dao, 2002, Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension, J Hypertens, 20, 1597, 10.1097/00004872-200208000-00023 Dao, 2005, Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension, Cardiovasc Res, 66, 307, 10.1016/j.cardiores.2005.01.012 Bouvet, 2005, Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition, Hypertension, 45, 432, 10.1161/01.HYP.0000154680.44184.01 Safar, 1995, Vascular compliance and blood volume in essential hypertension, 377 Labat, 2001, Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet, Hypertension, 38, 439, 10.1161/01.HYP.38.3.439 Sanders, 2004, Salt intake, endothelial cell signaling, and progression of kidney disease, Hypertension, 43, 142, 10.1161/01.HYP.0000114022.20424.22 Safar, 2005, Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system, J Hypertens, 23, 673, 10.1097/01.hjh.0000163130.39149.fe Bezie, 1998, Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats, Arterioscler Thromb Vasc Biol, 18, 1027, 10.1161/01.ATV.18.7.1027 Susic, 2004, Cross-link breakers: a new approach to cardiovascular therapy, Curr Opin Cardiol, 19, 336, 10.1097/01.hco.0000127135.73849.4f Kass, 2001, Improved arterial compliance by a novel advanced glycation end-product crosslink breaker, Circulation, 104, 1464, 10.1161/hc3801.097806 Comper, 1978, Physiological function of connective tissue polysaccharides, Physiol Rev, 58, 255, 10.1152/physrev.1978.58.1.255 Jackson, 1991, Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes, Physiol Rev, 71, 481, 10.1152/physrev.1991.71.2.481 Bevan, 1993, Flow regulation of vascular tone, Hypertension, 22, 273, 10.1161/01.HYP.22.3.273 Siegel, 1996, Blood flow sensing by anionic biopolymers, J Autonomic Nervous System, 57, 207, 10.1016/0165-1838(95)00071-2 Gandley, 1997, Contribution of chondroitin-dermatan sulfate-containing proteoglycans to the function of rat mesenteric arteries, Am J Physiol, 273, H952 Et-Taouil, 2004, Glycosaminoglycans et propriétés des gros troncs artériels, Med Sci, 20, 22 Et-Taouil, 2001, Sodium intake, large artery stiffness and proteoglycans in the SHR, Hypertension, 38, 1172, 10.1161/hy1101.96740 Lacolley, 2002, Increased carotid wall elastic modulus and fibronectin in aldosterone–salt treated rats—effects of eplerenone, Circulation, 106, 2848, 10.1161/01.CIR.0000039328.33137.6C Blasi, 2003, Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats, Kidney Int, 63, 1791, 10.1046/j.1523-1755.2003.00929.x Mitchell, 2004, Increased aortic stiffness: an unfavorable cardiorenal connection, Hypertension, 43, 151, 10.1161/01.HYP.0000114581.77705.29 London, 1989, Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery, Am J Hypertens, 2, 244, 10.1093/ajh/2.4.244 Holstein-Rathlou, 1994, Renal blood flow regulation and arterial pressure fluctuations: a case study in nonlinear dynamics, Physiol Rev, 74, 637, 10.1152/physrev.1994.74.3.637 Essig, 2001, Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells, Am J Physiol, 281, F751 Bidani, 2004, Pathophysiology of hypertensive renal damage: implications for therapy, Hypertension, 44, 595, 10.1161/01.HYP.0000145180.38707.84 Loutzenhiser, 2002, Renal myogenic response: kinetic attributes and physiological role, Circ Res, 90, 1316, 10.1161/01.RES.0000024262.11534.18 Verhave, 2005, Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension, Hypertension, 45, 586, 10.1161/01.HYP.0000158843.60830.cf Aoun, 2001, Diabetes mellitus and renal failure: effects on large artery stiffness, J Hum Hypertens, 15, 693, 10.1038/sj.jhh.1001253 Bahous, 2005, Aortic stiffness, living donors and renal transplantation, Hypertension, 47, 216, 10.1161/01.HYP.0000201234.35551.2e Fehrman-Ekholm, 1997, Kidney donors live longer, Transplantation, 64, 976, 10.1097/00007890-199710150-00007 Cortes, 1996, Regulation of glomerular volume in normal and partially nephrectomized rats, Am J Physiol, 270, F356 Safar, 2001, Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors, Curr Opin Nephrol Hypertens, 10, 257, 10.1097/00041552-200103000-00015 Hostetter, 1981, Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation, Am J Physiol, 241, F85 Plante, 1999, The blood vessel, linchpin of diabetic lesions, Metabolism, 48, 406, 10.1016/S0026-0495(99)90094-X